First Time Loading...

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.451 USD 4.57% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Redhill Biopharma Ltd Competitors:
Price Targets
AMPH
Amphastar Pharmaceuticals Inc
59% Upside
ANCR
Animalcare Group PLC
38% Upside
300497
Jiangxi Fushine Pharmaceutical Co Ltd
148% Upside
1093
CSPC Pharmaceutical Group Ltd
45% Upside
000640
Dong-A Socio Holdings Co Ltd
34% Upside
214370
Caregen Co Ltd
132% Upside
KDEV
Karolinska Development AB
187% Upside
PSG
PharmaSGP Holding SE
64% Upside

Revenue
Forecast

Revenue Estimate
Redhill Biopharma Ltd

The compound annual growth rate of Redhill Biopharma Ltd's revenue for the next 2 years is 144%.

N/A
Past Growth
144%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Redhill Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Redhill Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDHL's stock price target?
Not Available

RDHL doesn't have any price targets made by Wall Street professionals.

What is Redhill Biopharma Ltd's Revenue forecast?
Projected CAGR
144%

The compound annual growth rate of Redhill Biopharma Ltd's revenue for the next 2 years is 144%.